MedDataX Logo

Survey on PD Patients With Depressive Symptoms

NCT ID: NCT00614575

Last Updated: 2014-08-06

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1089 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this investigation is to conduct a 12-week prospective survey in PD patients with depressive symptoms treated with BI Sifrol Tablets (hereinafter referred to as this drug) in the routine clinical settings to determine the following items related to the safety and efficacy.

i. Adverse drug reaction symptoms, incidence, and severity ii. Motor capacity during the investigation iii. Depressive symptoms during the investigation

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease

NCT02231294

Parkinson Disease
COMPLETED

Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's Disease

NCT02248181

Parkinson Disease
COMPLETED

Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's Disease

NCT02231255

Parkinson Disease
COMPLETED

Long-term Administration Study of SND 919 Tablets in Parkinson's Disease

NCT00274131

Parkinson Disease
COMPLETED PHASE3

Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease Patients

NCT02073981

Parkinson Disease
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BI-Sifrol® Tablets (Pramipexole)

BI-Sifrol® Tablets, pramipexole dose: 0.125 mg, 0.5 mg, No reference therapy

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\*\*PD patients with depressive symptoms Patients who have not received pramipexole hydrochloride hydrate preparations within 1 month before survey entrance.

Exclusion Criteria

* PD patients with the past history of suicidal attempt, suicidal ideation or tendency
* PD patients with suicidal ideation
* PD patients with the past history of suicidal tendency
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boehringer Ingelheim

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Boehringer Ingelheim

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boehringer Ingelheim

Role: STUDY_CHAIR

Boehringer Ingelheim

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Boehringer Ingelheim Investigational Site

Akashi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Akita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Akita, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Asahikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ashikaga, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Awaji, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Chitose, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Chūō, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Fuchū, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Fuchū, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fuefuki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fuehuki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fujioka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fujisaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fujisawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fukaya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 3

Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 4

Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 5

Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Fukushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Fukushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Funabashi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Gifu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Gifu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Habikino, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hachiōji, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Hamamatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Hamamatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 3

Hamamatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 4

Hamamatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 5

Hamamatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hanamaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hayashima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Higashiosaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Higashiosaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Himeji, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hirakata, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hirishima, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hirosaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ibaraki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Iizuka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Inag, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Irima, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Isahaya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Iwaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Iwamizawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Iwata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Jyoetsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Jyoetsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Jyoyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Kagoshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Kagoshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 3

Kagoshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kahoku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kamakura, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Kanazawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Kanazawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Kanoya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Kanoya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Kashihara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Kashihara, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kasuga, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kawagchi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kawaguchi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Kawasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Kawasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kitakami, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Kiyose, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Kiyose, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kodaira, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kofu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Koga, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Komae, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Komatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Komatsushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Koshigaya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Kōriyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Kōriyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kōtari, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Kumamoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Kumamoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 3

Kumamoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kure, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kusatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 3

Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 4

Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Maebashi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Matsudo, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Matsumoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Mibu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Mihara, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Mihoro, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Miriyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Misato, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Miyako, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Miyazaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Miyazaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Moriguchi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Morioka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Morioka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Moriya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Mukai-awagasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Musashino, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nagaoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Nagoya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Nagoya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 3

Nagoya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 4

Nagoya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Nara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Nara, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Narashino, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Narita, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Narutō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nasushiobara, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nichinan, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ninohe, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nishinomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nishitōkyō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Okaya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Okayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Okayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Okazaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Okinawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Omuta, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 3

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 4

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 5

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 6

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōgaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōiso, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Ōita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Ōita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 3

Ōita, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōmura, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōnojō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōta-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōtake, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōtsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ryūgasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Saeki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Saga, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Sagamihara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Sagamihara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 3

Sagamihara, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Saijyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Sakai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Sakai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 3

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 4

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 5

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 6

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 7

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 8

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 9

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Sekigahara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Sendai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Sendai, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Shimoda, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Shimotsuke, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Shimotsuke, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Shinngu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Shiroishi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Shizuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Shizuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Shōwajima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Suita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Suita, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Susono, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Suzuka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Takaoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Takaoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Takatsuki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tarimizu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Togitsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokoname, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Arakawa-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Bunkyo-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Tokyo Chuo-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Tokyo Chuo-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Daito-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Koto-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Tokyo Meguro-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Tokyo Meguro-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Tokyo Minato-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Tokyo Minato-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 3

Tokyo Minato-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Nakano-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Nerima-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Tokyo Ota-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Tokyo Ota-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Setagaya-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Setagaya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Shibuya-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Shinagawa-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Tokyo Shinjyuku-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Tokyo Shinjyuku-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 3

Tokyo Shinjyuku-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Sibuya-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Toshima-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo-Edogawa-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo-Itabashi-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Toride, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tosu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Toyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Toyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 3

Toyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Toyohashi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Toyokawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Toyonaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ube, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ueda, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ushiku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Utsunomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Utsunomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Wakayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Yachiyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Yachiyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 3

Yachiyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yamanashi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yanago, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yoichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Yokohama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Yokohama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 3

Yokohama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 4

Yokohama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yokosuka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yoshinogawa, , Japan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Japan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

248.635

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Efficacy and Tolerability of Sifrol® (Pramipexole) in Patients With Advanced Idiopathic Parkinson's Disease
NCT02248220 COMPLETED
Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's Disease
NCT02248207 COMPLETED
Special Survey on PD Patients With Renal Dysfunction
NCT00613756 COMPLETED
Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease
NCT00228150 COMPLETED PHASE2
Improving Quality of Life in Early Parkinson's Disease
NCT04590612 UNKNOWN NA
Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's Disease
NCT05931575 UNKNOWN PHASE2
PF-06669571 In Subjects With Idiopathic Parkinson's Disease
NCT02565628 COMPLETED PHASE1
Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's Disease
NCT00220272 COMPLETED PHASE2
SEDPARK2: Post Marketing Surveillance to Observe Safety and Efficacy of Piribedil in Parkinson's Disease (PIR-002/K)
NCT00727727 COMPLETED
Idebenone Treatment of Early Parkinson's Diseasesymptoms
NCT03727295 UNKNOWN PHASE4
A Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects with Early Parkinson's Disease
NCT06175767 NOT_YET_RECRUITING PHASE2
Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease
NCT00438607 COMPLETED PHASE2
SEDPARK1: Safety and Efficacy Study With the Non-ergot Dopamine-agonist Piribedil in Parkinson's Disease
NCT00725478 COMPLETED
Simvastatin as a Neuroprotective Treatment for Moderate Parkinson's Disease
NCT02787590 COMPLETED PHASE2
Dose-Finding Safety Study of BIIB014 in Early-Stage Parkinson's Disease
NCT00442780 COMPLETED PHASE2
Randomized Clinical Trial of Donepezil for the Treatment of Mild Cognitive Impairment in Parkinson's Disease
NCT05709301 NOT_YET_RECRUITING PHASE2
Non-interventional Observational Study With Pramipexole: Impact on Non-motor Symptoms in Parkinson's Disease
NCT00539214 COMPLETED
Role of Pentoxifylline and Celecoxib in Parkinsonism
NCT05962957 COMPLETED PHASE2
A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)
NCT00148486 COMPLETED PHASE2
Treatment of Depression in Parkinson's Disease
NCT01416818 UNKNOWN PHASE2
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
NCT02006290 COMPLETED PHASE1
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
NCT02610231 COMPLETED PHASE3
A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease
NCT00250393 COMPLETED PHASE2
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Japanese Participants With Parkinson's Disease
NCT03716570 TERMINATED PHASE1
Study to Evaluate SYN115 in Parkinson's Disease
NCT00605553 COMPLETED PHASE2